CHARLOTTE, N.C., Oct. 1, 2009 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will host a conference call and live webcast to discuss the previously reported results of its Phase III trial of Droxidopa in neurogenic orthostatic hypotension after the market closes at 4:30 PM ET.
